Predictors of adherence to safe handling practices for antineoplastic drugs: A survey of hospital nurses

References

• American Society of Hospital Pharmacists (ASPH): ASHP guidelines on handling hazardous drugs. Am. J. Health Syst. Pharm. 63:1172–1193 (2006).
   Google Scholar
• National Institute for Occupational Safety and Health (NIOSH): “NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings.” National Institute for Occupational Safety and Health 2004. Available at http://www.cdc.gov/niosh/docs/2004-165/ (accessed April 21, 2015).
   Google Scholar
• Occupational Safety and Health Administration (OSHA): “Controlling Occupational Exposure to Hazardous Drugs.” OSHA Technical Manual, TED 1-0.15A, section VI, chapter 2: Occupational Safety and Health Administration 1999. Available at https://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html (accessed April 21, 2015).
   Google Scholar
• Polovich, M., J.M. White, and M. Olsen: Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. 3rd ed. Pittsburgh, PA: Oncology Nursing Society (2009).
   Google Scholar
• Boiano, J.M., A.L. Steege, and M.H. Sweeney: Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J. Occup. Environ. Hyg. 11:728–740 (2014).
   PubMed Web of Science ®Google Scholar
• Polovich, M, and S. Martin: Nurses' use of hazardous drug-handling precautions and awareness of national safety guidelines. Oncol. Nurs. Forum 38:718–726 (2011).
   PubMed Web of Science ®Google Scholar
• Martin, S., and E. Larson: Chemotherapy-handling practices of outpatient and office-based oncology nurses. Oncol. Nurs. Forum. 30:575–581 (2003).
   PubMedGoogle Scholar
• Fuller, T.P., E.I. Bain, and K. Sperrazza: A survey of the status of hazardous drug awareness and control in a sample Massachusetts nursing population. J. Occup. Environ. Hyg. 4:D113–9 (2007).
   Google Scholar
• Friese, C.R., L. Himes-Ferris, M.N. Frasier, M.C. McCullagh, and J.J. Griggs: Structures and processes of care in ambulatory oncology settings and nurse-reported exposure to chemotherapy. BMJ Qual. Saf. 21:753–759 (2012).
   PubMed Web of Science ®Google Scholar
• Hon, C.Y., K. Teschke, and H. Shen: Healthcare workers' knowledge, perceptions and behaviors regarding antineoplastic drugs: Survey from British Columbia, Canada. J. Occup. Environ. Hyg. 12:669–677 (2015).
   Google Scholar
• Connor, T.H., and M.A. McDiarmid: Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J. Clin. 56:354–365 (2006).
   PubMed Web of Science ®Google Scholar
• Hedmer, M., H. Tinnerberg, A. Axmon, and B.A. Jonsson: Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Int. Arch. Occup. Environ. Health 81:899–911 (2008).
   PubMed Web of Science ®Google Scholar
• Sottani, C., B. Porro, M. Imbriani, and C. Minoia: Occupational exposure to antineoplastic drugs in four Italian health care settings. Toxicol. Lett. 213:107–115 (2012).
   PubMed Web of Science ®Google Scholar
• Guillemette, A., H. Langlois, M. Voisine, et al.: Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device. J. Oncol. Pharm. Pract. 20:426–432 (2014).
   PubMedGoogle Scholar
• Connor, T.H., D.G. DeBord, J.R. Pretty, et al.: Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. J. Occup. Environ. Med. 52:1019–1027 (2010).
   PubMed Web of Science ®Google Scholar
• Ben-Ami, S., J. Shaham, S. Rabin, A. Melzer, and J. Ribak: The influence of nurses' knowledge, attitudes, and health beliefs on their safe behavior with cytotoxic drugs in Israel. Cancer Nurs. 24:192–200 (2001).
   PubMed Web of Science ®Google Scholar
• Friese, C.R., and M. Manojlovich: Nurse-physician relationships in ambulatory oncology settings. J. Nurs. Scholarsh. 44:258–265 (2012).
   PubMed Web of Science ®Google Scholar
• Keller, S.M.: Effects of extended work shifts and shift work on patient safety, productivity, and employee health. AAOHN J. 57:497–504 (2009).
   PubMedGoogle Scholar
• Wagstaff, A.S., and J.A. Sigstad Lie: Shift and night work and long working hours–a systematic review of safety implications. Scand. J. Work Environ. Health 37:173–185 (2011).
   PubMed Web of Science ®Google Scholar
• Steege, A.L., J.M. Boiano, and M.H. Sweeney: NIOSH health and safety practices survey of healthcare workers: training and awareness of employer safety procedures. Am. J. Ind. Med. 57:640–652 (2014).
   PubMed Web of Science ®Google Scholar
• Bland, J.M., and D.G. Altman: Multiple significance tests: the Bonferroni method. BMJ 310:170 (1995).
   PubMed Web of Science ®Google Scholar
• Perneger, T.V.: What's wrong with Bonferroni adjustments. BMJ 316:1236–1238 (1998).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC): “Distinguishing Public Health Research and Public Health Nonresearch.” Avaialable at http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-helath-research-nonresearch.pdf (accessed May 5, 2015).
   Google Scholar
• Kopp, B., R. Schierl, and D. Nowak: Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings. Int. Arch. Occup. Environ. Health 86:47–55 (2013).
   PubMed Web of Science ®Google Scholar
• Fransman, W., S. Peelen, S. Hilhorst, N. Roeleveld, D. Heederik, and H. Kromhout: A pooled analysis to study trends in exposure to antineoplastic drugs among nurses. Ann. Occup. Hyg. 51:231–239 (2007).
   PubMed Web of Science ®Google Scholar
• Dusetzina, S.B., E. Basch, and N.L. Keating: For uninsured cancer patients, outpatient charges can be costly, putting treatments out of reach. Health Aff. 34:584–591 (2015).
   Web of Science ®Google Scholar
• Vyas, N., D. Yiannakis, A. Turner, and G.J. Sewell: Occupational exposure to anti-cancer drugs: A review of effects of new technology. J. Oncol. Pharm. Pract. 20:278–287 (2013).
   PubMedGoogle Scholar
• Landeck, L., E. Gonzalez, and O.M. Koch: Handling chemotherapy drugs—Do medical gloves really protect? Int. J. Cancer 137:1800–1805 (2014).
   Google Scholar
• Odraska, P., L. Dolezalova, J. Kuta, M. Oravec, P. Piler, and L. Blaha: Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs. Ann. Occup. Hyg. 57:240–50 (2013).
   PubMed Web of Science ®Google Scholar
• Jorgenson, J.A., S.M. Spivey, D. Canann, H. Ritter, and B. Smith: Contamination comparison of transfer devices intended for handling hazardous drugs. Hosp. Pharm. 43:723–727 (2008).
   Google Scholar
• U.S. Pharmacopeial Convention (USP): “General Chapter <800>Hazardous Drugs – Handling in Healthcare Settings.” Available at http://www.usp.org/usp-nf/notices/general-chapter-hazardous-drugs-handling-healthcare-settings. (accessed May 5, (2015)).
   Google Scholar